{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:34:13Z","timestamp":1782977653588,"version":"3.54.5"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosci. Bull."],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s12264-025-01374-8","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T08:02:12Z","timestamp":1741593732000},"page":"1181-1197","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Interleukin-33 Knockout Promotes High Mobility Group Box 1 Release from Astrocytes by Acetylation Mediated by P300\/CBP-Associated Factor in Experimental Autoimmune Encephalomyelitis"],"prefix":"10.1007","volume":"41","author":[{"given":"Yifan","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyan","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyao","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangxingzi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingshan","family":"Pi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youhua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuran","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7415-6230","authenticated-orcid":false,"given":"Xiji","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7833-0497","authenticated-orcid":false,"given":"Yiyuan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"key":"1374_CR1","doi-asserted-by":"crossref","unstructured":"Olek MJ. Multiple sclerosis. Ann Intern Med 2021, 174: ITC81\u2013ITC96.","DOI":"10.7326\/AITC202106150"},{"key":"1374_CR2","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s12264-023-01034-9","volume":"39","author":"Y Sun","year":"2023","unstructured":"Sun Y, Yu H, Guan Y. Glia connect inflammation and neurodegeneration in multiple sclerosis. Neurosci Bull 2023, 39: 466\u2013478.","journal-title":"Neurosci Bull"},{"key":"1374_CR3","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jama.2020.26858","volume":"325","author":"MP McGinley","year":"2021","unstructured":"McGinley MP, Goldschmidt CH, Rae-Grant AD. Diagnosis and treatment of multiple sclerosis: A review. JAMA 2021, 325: 765\u2013779.","journal-title":"JAMA"},{"key":"1374_CR4","doi-asserted-by":"crossref","first-page":"a028977","DOI":"10.1101\/cshperspect.a028977","volume":"8","author":"S Glatigny","year":"2018","unstructured":"Glatigny S, Bettelli E. Experimental autoimmune encephalomyelitis (EAE) as animal models of multiple sclerosis (MS). Cold Spring Harb Perspect Med 2018, 8: a028977.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1374_CR5","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/nrneurol.2009.178","volume":"5","author":"A Degenhardt","year":"2009","unstructured":"Degenhardt A, Ramagopalan SV, Scalfari A, Ebers GC. Clinical prognostic factors in multiple sclerosis: A natural history review. Nat Rev Neurol 2009, 5: 672\u2013682.","journal-title":"Nat Rev Neurol"},{"key":"1374_CR6","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41582-023-00801-6","volume":"19","author":"L Klotz","year":"2023","unstructured":"Klotz L, Antel J, Kuhlmann T. Inflammation in multiple sclerosis: Consequences for remyelination and disease progression. Nat Rev Neurol 2023, 19: 305\u2013320.","journal-title":"Nat Rev Neurol"},{"key":"1374_CR7","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.neuron.2015.01.013","volume":"85","author":"SP Gadani","year":"2015","unstructured":"Gadani SP, Walsh JT, Smirnov I, Zheng J, Kipnis J. The Glia-derived alarmin IL-33 orchestrates the immune response and promotes recovery following CNS injury. Neuron 2015, 85: 703\u2013709.","journal-title":"Neuron"},{"key":"1374_CR8","first-page":"75","volume":"15","author":"KM Hamid","year":"2016","unstructured":"Hamid KM, Nejati A, Shoja Z, Mollaei-Kandelousd Y, Doosti R, Mirshafiey A. Quantitative evaluation of BAFF, HMGB1, TLR 4 AND TLR 7 expression in patients with relapsing remitting multiple sclerosis. Iran J Allergy Asthma Immunol 2016, 15: 75\u201381.","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"1374_CR9","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s10495-021-01663-3","volume":"26","author":"A Murao","year":"2021","unstructured":"Murao A, Aziz M, Wang H, Brenner M, Wang P. Release mechanisms of major DAMPs. Apoptosis 2021, 26: 152\u2013162.","journal-title":"Apoptosis"},{"key":"1374_CR10","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","volume":"23","author":"J Schmitz","year":"2005","unstructured":"Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005, 23: 479\u2013490.","journal-title":"Immunity"},{"key":"1374_CR11","doi-asserted-by":"crossref","first-page":"703","DOI":"10.4049\/jimmunol.1501820","volume":"196","author":"CM Finlay","year":"2016","unstructured":"Finlay CM, Stefanska AM, Walsh KP, Kelly PJ, Boon L, Lavelle EC, et al. Helminth products protect against autoimmunity via innate type 2 cytokines IL-5 and IL-33, which promote eosinophilia. J Immunol 2016, 196: 703\u2013714.","journal-title":"J Immunol"},{"key":"1374_CR12","doi-asserted-by":"crossref","first-page":"E1520","DOI":"10.1073\/pnas.1710401115","volume":"115","author":"AE Russi","year":"2018","unstructured":"Russi AE, Ebel ME, Yang Y, Brown MA. Male-specific IL-33 expression regulates sex-dimorphic EAE susceptibility. Proc Natl Acad Sci USA 2018, 115: E1520\u2013E1529.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1374_CR13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neuroscience.2015.09.019","volume":"308","author":"H Chen","year":"2015","unstructured":"Chen H, Sun Y, Lai L, Wu H, Xiao Y, Ming B, et al. Interleukin-33 is released in spinal cord and suppresses experimental autoimmune encephalomyelitis in mice. Neuroscience 2015, 308: 157\u2013168.","journal-title":"Neuroscience"},{"key":"1374_CR14","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.molimm.2018.08.026","volume":"101","author":"Y Xiao","year":"2018","unstructured":"Xiao Y, Lai L, Chen H, Shi J, Zeng F, Li J, et al. Interleukin-33 deficiency exacerbated experimental autoimmune encephalomyelitis with an influence on immune cells and Glia cells. Mol Immunol 2018, 101: 550\u2013563.","journal-title":"Mol Immunol"},{"key":"1374_CR15","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1002\/eji.201141947","volume":"42","author":"HR Jiang","year":"2012","unstructured":"Jiang HR, Milovanovi\u0107 M, Allan D, Niedbala W, Besnard AG, Fukada SY, et al. IL-33 attenuates EAE by suppressing IL-17 and IFN-\u03b3 production and inducing alternatively activated macrophages. Eur J Immunol 2012, 42: 1804\u20131814.","journal-title":"Eur J Immunol"},{"key":"1374_CR16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jaut.2013.02.005","volume":"43","author":"AP Robinson","year":"2013","unstructured":"Robinson AP, Caldis MW, Harp CT, Goings GE, Miller SD. High-mobility group box 1 protein (HMGB1) neutralization ameliorates experimental autoimmune encephalomyelitis. J Autoimmun 2013, 43: 32\u201343.","journal-title":"J Autoimmun"},{"key":"1374_CR17","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1172\/JCI41360","volume":"120","author":"N Matsuoka","year":"2010","unstructured":"Matsuoka N, Itoh T, Watarai H, Sekine-Kondo E, Nagata N, Okamoto K, et al. High-mobility group box 1 is involved in the initial events of early loss of transplanted islets in mice. J Clin Invest 2010, 120: 735\u2013743.","journal-title":"J Clin Invest"},{"key":"1374_CR18","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1189\/jlb.1207844","volume":"84","author":"A Andersson","year":"2008","unstructured":"Andersson A, Covacu R, Sunnemark D, Danilov AI, Dal Bianco A, Khademi M, et al. Pivotal advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis. J Leukoc Biol 2008, 84: 1248\u20131255.","journal-title":"J Leukoc Biol"},{"key":"1374_CR19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.msard.2019.03.030","volume":"31","author":"C Zhen","year":"2019","unstructured":"Zhen C, Wang Y, Li D, Zhang W, Zhang H, Yu X, et al. Relationship of High-mobility group box 1 levels and multiple sclerosis: A systematic review and meta-analysis. Mult Scler Relat Disord 2019, 31: 87\u201392.","journal-title":"Mult Scler Relat Disord"},{"key":"1374_CR20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jneuroim.2015.02.005","volume":"280","author":"Y Sun","year":"2015","unstructured":"Sun Y, Chen H, Dai J, Zou H, Gao M, Wu H, et al. HMGB1 expression patterns during the progression of experimental autoimmune encephalomyelitis. J Neuroimmunol 2015, 280: 29\u201335.","journal-title":"J Neuroimmunol"},{"key":"1374_CR21","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s12264-022-00890-1","volume":"38","author":"J Shi","year":"2022","unstructured":"Shi J, Xiao Y, Zhang N, Jiao M, Tang X, Dai C, et al. HMGB1 from astrocytes promotes EAE by influencing the immune cell infiltration-associated functions of BMECs in mice. Neurosci Bull 2022, 38: 1303\u20131314.","journal-title":"Neurosci Bull"},{"key":"1374_CR22","doi-asserted-by":"crossref","first-page":"7889","DOI":"10.4049\/jimmunol.177.11.7889","volume":"177","author":"JH Youn","year":"2006","unstructured":"Youn JH, Shin JS. Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion. J Immunol 2006, 177: 7889\u20137897.","journal-title":"J Immunol"},{"key":"1374_CR23","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1089\/ars.2015.6409","volume":"24","author":"Y Tang","year":"2016","unstructured":"Tang Y, Zhao X, Antoine D, Xiao X, Wang H, Andersson U, et al. Regulation of posttranslational modifications of HMGB1 during immune responses. Antioxid Redox Signal 2016, 24: 620\u2013634.","journal-title":"Antioxid Redox Signal"},{"key":"1374_CR24","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.3390\/cells10123323","volume":"10","author":"U Andersson","year":"2021","unstructured":"Andersson U, Tracey KJ, Yang H. Post-translational modification of HMGB1 disulfide bonds in stimulating and inhibiting inflammation. Cells 2021, 10: 3323.","journal-title":"Cells"},{"key":"1374_CR25","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.bbagrm.2009.11.009","volume":"1799","author":"Q Zhang","year":"2010","unstructured":"Zhang Q, Wang Y. HMG modifications and nuclear function. Biochim Biophys Acta 2010, 1799: 28\u201336.","journal-title":"Biochim Biophys Acta"},{"key":"1374_CR26","doi-asserted-by":"crossref","first-page":"110653","DOI":"10.1016\/j.intimp.2023.110653","volume":"122","author":"M Jiao","year":"2023","unstructured":"Jiao M, Sun Y, Shi J, Zhang N, Tang X, Fan A, et al. IL-33 and HMGB1 modulate the progression of EAE via oppositely regulating each other. Int Immunopharmacol 2023, 122: 110653.","journal-title":"Int Immunopharmacol"},{"key":"1374_CR27","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S1474-4422(21)00170-8","volume":"20","author":"TL Neurology","year":"2021","unstructured":"Neurology TL. Multiple sclerosis under the spotlight. Lancet Neurol 2021, 20: 497.","journal-title":"Lancet Neurol"},{"key":"1374_CR28","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1001\/jama.2022.14236","volume":"328","author":"R Marcus","year":"2022","unstructured":"Marcus R. What is multiple sclerosis? Jama 2022, 328: 2078.","journal-title":"Jama"},{"key":"1374_CR29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3988\/jcn.2022.0208","volume":"19","author":"AB Baskaran","year":"2023","unstructured":"Baskaran AB, Grebenciucova E, Shoemaker T, Graham EL. Current updates on the diagnosis and management of multiple sclerosis for the general neurologist. J Clin Neurol 2023, 19: 217\u2013229.","journal-title":"J Clin Neurol"},{"key":"1374_CR30","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nri.2016.95","volume":"16","author":"FY Liew","year":"2016","unstructured":"Liew FY, Girard JP, Turnquist HR. Interleukin-33 in health and disease. Nat Rev Immunol 2016, 16: 676\u2013689.","journal-title":"Nat Rev Immunol"},{"key":"1374_CR31","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s12264-011-1025-5","volume":"27","author":"P Han","year":"2011","unstructured":"Han P, Mi WL, Wang YQ. Research progress on interleukin-33 and its roles in the central nervous system. Neurosci Bull 2011, 27: 351\u2013357.","journal-title":"Neurosci Bull"},{"key":"1374_CR32","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.21037\/atm.2016.10.22","volume":"4","author":"Y Xiao","year":"2016","unstructured":"Xiao Y, Zheng F. The emerging role of sST2 blocking in the therapy of graft-versus-host disease. Ann Transl Med 2016, 4: S42.","journal-title":"Ann Transl Med"},{"key":"1374_CR33","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bbi.2024.04.028","volume":"119","author":"M Jiao","year":"2024","unstructured":"Jiao M, Wang C, Tang X, Dai C, Zhang N, Fan A, et al. Active secretion of IL-33 from astrocytes is dependent on TMED10 and promotes central nervous system homeostasis. Brain Behav Immun 2024, 119: 539\u2013553.","journal-title":"Brain Behav Immun"},{"key":"1374_CR34","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.3389\/fimmu.2018.01518","volume":"9","author":"Y Sun","year":"2018","unstructured":"Sun Y, Chen H, Dai J, Wan Z, Xiong P, Xu Y, et al. Glycyrrhizin protects mice against experimental autoimmune encephalomyelitis by inhibiting high-mobility group box 1 (HMGB1) expression and neuronal HMGB1 release. Front Immunol 2018, 9: 1518.","journal-title":"Front Immunol"},{"key":"1374_CR35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/cei.12036","volume":"172","author":"A Uzawa","year":"2013","unstructured":"Uzawa A, Mori M, Taniguchi J, Masuda S, Muto M, Kuwabara S. Anti-high mobility group box 1 monoclonal antibody ameliorates experimental autoimmune encephalomyelitis. Clin Exp Immunol 2013, 172: 37\u201343.","journal-title":"Clin Exp Immunol"},{"key":"1374_CR36","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1089\/dna.2018.4592","volume":"38","author":"Y Wang","year":"2019","unstructured":"Wang Y, Wang L, Gong Z. Regulation of acetylation in high mobility group protein B1 cytosol translocation. DNA Cell Biol 2019, 38: 491\u2013499.","journal-title":"DNA Cell Biol"},{"key":"1374_CR37","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12974-018-1151-3","volume":"15","author":"X Chen","year":"2018","unstructured":"Chen X, Chen C, Fan S, Wu S, Yang F, Fang Z, et al. Omega-3 polyunsaturated fatty acid attenuates the inflammatory response by modulating microglia polarization through SIRT1-mediated deacetylation of the HMGB1\/NF-\u03baB pathway following experimental traumatic brain injury. J Neuroinflammation 2018, 15: 116.","journal-title":"J Neuroinflammation"},{"key":"1374_CR38","doi-asserted-by":"crossref","first-page":"e87915","DOI":"10.1371\/journal.pone.0087915","volume":"9","author":"JY Zou","year":"2014","unstructured":"Zou JY, Crews FT. Release of neuronal HMGB1 by ethanol through decreased HDAC activity activates brain neuroimmune signaling. PLoS One 2014, 9: e87915.","journal-title":"PLoS One"},{"key":"1374_CR39","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.bbi.2018.11.313","volume":"76","author":"B Xu","year":"2019","unstructured":"Xu B, Zang SC, Li SZ, Guo JR, Wang JF, Wang D, et al. HMGB1-mediated differential response on hippocampal neurotransmitter disorder and neuroinflammation in adolescent male and female mice following cold exposure. Brain Behav Immun 2019, 76: 223\u2013235.","journal-title":"Brain Behav Immun"},{"key":"1374_CR40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jdermsci.2022.01.006","volume":"105","author":"H Tsuda","year":"2022","unstructured":"Tsuda H, Tominaga SI, Ohtsuki M, Komine M. Nuclear IL-33 regulates cytokinesis and cell motility in normal human epidermal keratinocytes. J Dermatol Sci 2022, 105: 113\u2013120.","journal-title":"J Dermatol Sci"},{"key":"1374_CR41","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.4049\/jimmunol.1003080","volume":"187","author":"S Ali","year":"2011","unstructured":"Ali S, Mohs A, Thomas M, Klare J, Ross R, Schmitz ML, et al. The dual function cytokine IL-33 interacts with the transcription factor NF-\u03baB to dampen NF-\u03baB-stimulated gene transcription. J Immunol 2011, 187: 1609\u20131616.","journal-title":"J Immunol"},{"key":"1374_CR42","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1038\/s41467-018-05485-x","volume":"9","author":"J Travers","year":"2018","unstructured":"Travers J, Rochman M, Miracle CE, Habel JE, Brusilovsky M, Caldwell JM, et al. Chromatin regulates IL-33 release and extracellular cytokine activity. Nat Commun 2018, 9: 3244.","journal-title":"Nat Commun"},{"key":"1374_CR43","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/cac2.12473","volume":"43","author":"Q Li","year":"2023","unstructured":"Li Q, Gan B. Uncovering the IL-1\u03b2-PCAF-NNT axis: A new player in ferroptosis and tumor immune evasion. Cancer Commun (Lond) 2023, 43: 1048\u20131050.","journal-title":"Cancer Commun (Lond)"},{"key":"1374_CR44","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.molcel.2020.08.018","volume":"80","author":"JJ Kim","year":"2020","unstructured":"Kim JJ, Lee SY, Choi JH, Woo HG, Xhemalce B, Miller KM. PCAF-mediated histone acetylation promotes replication fork degradation by MRE11 and EXO1 in BRCA-deficient cells. Mol Cell 2020, 80: 327-344.e8.","journal-title":"Mol Cell"},{"key":"1374_CR45","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.celrep.2017.08.015","volume":"20","author":"M Zhao","year":"2017","unstructured":"Zhao M, Geng R, Guo X, Yuan R, Zhou X, Zhong Y, et al. PCAF\/GCN5-mediated acetylation of RPA1 promotes nucleotide excision repair. Cell Rep 2017, 20: 1997\u20132009.","journal-title":"Cell Rep"},{"key":"1374_CR46","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1074\/jbc.M806075200","volume":"284","author":"N Blanco-Garc\u00eda","year":"2009","unstructured":"Blanco-Garc\u00eda N, Asensio-Juan E, de la Cruz X, Mart\u00ednez-Balb\u00e1s MA. Autoacetylation regulates P\/CAF nuclear localization. J Biol Chem 2009, 284: 1343\u20131352.","journal-title":"J Biol Chem"},{"key":"1374_CR47","doi-asserted-by":"crossref","first-page":"1094925","DOI":"10.3389\/fimmu.2022.1094925","volume":"13","author":"Y Mo","year":"2023","unstructured":"Mo Y, Chen K. Review: The role of HMGB1 in spinal cord injury. Front Immunol 2023, 13: 1094925.","journal-title":"Front Immunol"},{"key":"1374_CR48","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.4049\/jimmunol.0903131","volume":"184","author":"M Penzo","year":"2010","unstructured":"Penzo M, Molteni R, Suda T, Samaniego S, Raucci A, Habiel DM, et al. Inhibitor of NF-kappa B kinases alpha and beta are both essential for high mobility group box 1-mediated chemotaxis [corrected. J Immunol 2010, 184: 4497\u20134509.","journal-title":"J Immunol"},{"key":"1374_CR49","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrn1824","volume":"7","author":"N Joan Abbott","year":"2006","unstructured":"Joan Abbott N, R\u00f6nnb\u00e4ck L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006, 7: 41\u201353.","journal-title":"Nat Rev Neurosci"},{"key":"1374_CR50","doi-asserted-by":"crossref","first-page":"8370","DOI":"10.3390\/ijms22168370","volume":"22","author":"R Balasa","year":"2021","unstructured":"Balasa R, Barcutean L, Mosora O, Manu D. Reviewing the significance of blood-brain barrier disruption in multiple sclerosis pathology and treatment. Int J Mol Sci 2021, 22: 8370.","journal-title":"Int J Mol Sci"},{"key":"1374_CR51","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/SHK.0b013e3181f6aab0","volume":"35","author":"R Dhupar","year":"2011","unstructured":"Dhupar R, Klune JR, Evankovich J, Cardinal J, Zhang M, Ross M, et al. Interferon regulatory factor 1 mediates acetylation and release of high mobility group box 1 from hepatocytes during murine liver ischemia-reperfusion injury. Shock 2011, 35: 293\u2013301.","journal-title":"Shock"},{"key":"1374_CR52","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1073\/pnas.1316925111","volume":"111","author":"B Lu","year":"2014","unstructured":"Lu B, Antoine DJ, Kwan K, Lundb\u00e4ck P, W\u00e4h\u00e4maa H, Schierbeck H, et al. JAK\/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation. Proc Natl Acad Sci USA 2014, 111: 3068\u20133073.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1374_CR53","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/ki.2014.217","volume":"87","author":"MM Rabadi","year":"2015","unstructured":"Rabadi MM, Xavier S, Vasko R, Kaur K, Goligorksy MS, Ratliff BB. High-mobility group box 1 is a novel deacetylation target of Sirtuin1. Kidney Int 2015, 87: 95\u2013108.","journal-title":"Kidney Int"},{"key":"1374_CR54","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41418-021-00841-9","volume":"29","author":"K Yang","year":"2022","unstructured":"Yang K, Fan M, Wang X, Xu J, Wang Y, Tu F, et al. Lactate promotes macrophage HMGB1 lactylation, acetylation, and exosomal release in polymicrobial sepsis. Cell Death Differ 2022, 29: 133\u2013146.","journal-title":"Cell Death Differ"}],"container-title":["Neuroscience Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-025-01374-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12264-025-01374-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-025-01374-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T19:03:02Z","timestamp":1751569382000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12264-025-01374-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":54,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["1374"],"URL":"https:\/\/doi.org\/10.1007\/s12264-025-01374-8","relation":{},"ISSN":["1673-7067","1995-8218"],"issn-type":[{"value":"1673-7067","type":"print"},{"value":"1995-8218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,10]]},"assertion":[{"value":"17 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there are no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}